Once-Daily Oral Treatment for Metastatic Prostate Cancer Approved - Renal and Urology News

Links shared publicly online about this topic.

  • 323
    total visits

Once-Daily Oral Treatment for Metastatic Prostate Cancer Approved - Renal and Urology News

renalandurologynews.com

The FDA has approved an oral, once-daily medication for use in combination with prednisone for the treatment of men with metastatic castration-resistant prostate cancer (CRPC) who have received prior chemotherapy.

View full resource at renalandurologynews.com

Tags: Cancer, Prostate Cancer, Kidney Health, Urinary System, Prostate, Men's Health, FDA

  • Share

Most Recently Shared on May 2, 2011 at 11:50 am By:

prostatecancer_ Prostate Cancer

Once-Daily Oral Treatment for Metastatic Prostate Cancer Approved http://bit.ly/iQRaKl

1 year ago...

Also Shared By:

Renal Urology News Renal Urology News

Late-breaking news: FDA approves Zytiga for late-stage prostate cancer - - ModernMedicine

modernmedicine.com — “FDA has approved abiraterone acetate (Zytiga, Centocor Ortho Biotech), an oral, once-daily medication for use in combination with prednisone for the treatment of men with metastatic castration-resistant prostate cancer who have received prior chemotherapy containing docetaxel.View full resource at modernmedicine.com

  • View Related
  • Share

Most Recently Shared on April 29, 2011 at 7:34 pm By:

rlanzara Richard G. Lanzara Health Professional

Late-breaking news: FDA approves Zytiga for late-stage prostate cancer - http://bit.ly/mj3aag #health #medicine

1 year ago...

Zytiga Approved for Metastatic Prostate Cancer - MPR

empr.com — “Centocor Ortho Biotech announced that the FDA has approved Zytiga (abiraterone acetate), an oral, once-daily medication for use in combination with prednisone for the treatment of men with metastatic castration-resistant prostate cancer who have received prior chemotherapy containing docetaxel.View full resource at empr.com

  • View Related
  • Share

Most Recently Shared on April 28, 2011 at 8:41 pm By:

eMPR MPR Medical Publisher

MPR News: Zytiga Approved for Metastatic Prostate Cancer: Centocor Ortho Biotech announced that the FDA has appr... http://bit.ly/j9FCAQ

1 year ago...

Advertisement